Cryo-Cell International Inc (CCEL) has a current Price-to-Book (P/B) ratio of -1.86. Compared to its 3-year average P/B ratio of -241.13, the current P/B ratio is approximately -99.23% higher. Relative to its 5-year average P/B ratio of -143.88, the current P/B ratio is about -98.71% higher. Cryo-Cell International Inc (CCEL) has a Forward Free Cash Flow (FCF) yield of approximately 22.38%. Compared to its 3-year average FCF yield of 4.57%, the current FCF yield is approximately 389.98% lower. Relative to its 5-year average FCF yield of 4.33%, the current FCF yield is about 416.84% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CCEL competitors is 0.90, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL.A) exhibits a P/S ratio of 0.91, which is 2% above the industry average. Given its robust revenue growth of -2.99%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CCEL increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CCEL in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CCEL currently overvalued or undervalued?

What is Cryo-Cell International Inc (CCEL) fair value?

CCEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cryo-Cell International Inc (CCEL) is between 2.50 to 6.80 according to relative valuation method.

How does CCEL's valuation metrics compare to the industry average?

The average P/S ratio for CCEL's competitors is 0.90, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL) exhibits a P/S ratio of 0.91, which is 2.00% above the industry average. Given its robust revenue growth of -2.99%, this premium appears unsustainable.

What is the current P/B ratio for Cryo-Cell International Inc (CCEL) as of Mar 03 2026?

As of Mar 03 2026, Cryo-Cell International Inc (CCEL) has a P/B ratio of -1.86. This indicates that the market values CCEL at -1.86 times its book value.

What is the current FCF Yield for Cryo-Cell International Inc (CCEL) as of Mar 03 2026?

As of Mar 03 2026, Cryo-Cell International Inc (CCEL) has a FCF Yield of 22.38%. This means that for every dollar of Cryo-Cell International Inc's market capitalization, the company generates 22.38 cents in free cash flow.

What is the current Forward P/E ratio for Cryo-Cell International Inc (CCEL) as of Mar 03 2026?

As of Mar 03 2026, Cryo-Cell International Inc (CCEL) has a Forward P/E ratio of -8.79. This means the market is willing to pay $-8.79 for every dollar of Cryo-Cell International Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cryo-Cell International Inc (CCEL) as of Mar 03 2026?

As of Mar 03 2026, Cryo-Cell International Inc (CCEL) has a Forward P/S ratio of 0.91. This means the market is valuing CCEL at $0.91 for every dollar of expected revenue over the next 12 months.

CCEL Valuation